Skip to main content
. 2021 Mar 17;10(7):e018381. doi: 10.1161/JAHA.120.018381

Table 2.

Associations of Prebeta‐1 HDL Tertiles With CHD and MI in Cohort 2

ORs CHD MI
OR (95% CI) P Value OR (95% CI) P Value
Unadjusted
Percent prebeta‐1 HDL tertile 1 1.00 (reference) 1.00 (reference)
Tertile 2 1.67 (1.21–2.29) 0.002 1.75 (1.10–2.78) 0.017
Tertile 3 2.09 (1.53–2.87) <0.001 2.26 (1.44–3.53) <0.001
Adjusted
Percent prebeta‐1 HDL tertile 1 1.00 (reference) 1.00 (reference)
Tertile 2 1.42 (0.97–2.09) 0.076 1.38 (0.82–2.31) 0.226
Tertile 3 1.81 (1.20–2.73) 0.005 2.12 (1.24–3.63) 0.006
Unadjusted
Absolute prebeta‐1 HDL tertile 1 1.00 (reference) 1.00 (reference)
Tertile 2 1.62 (1.18–2.24) 0.003 1.74 (1.11–2.71) 0.015
Tertile 3 2.24 (1.64–3.07) <0.001 1.79 (1.15–2.79) 0.010
Adjusted
Absolute prebeta‐1 HDL tertile 1 1.00 (reference) 1.00 (reference)
Tertile 2 1.28 (0.86–1.90) 0.220 1.53 (0.92–2.57) 0.105
Tertile 3 2.12 (1.41–3.20) <0.001 1.90 (1.09–3.30) 0.024

Unadjusted and adjusted ORs and 95% CIs for tertiles of both percent prebeta‐1 HDL (percent of total plasma apolipoprotein A‐I) and absolute prebeta‐1 HDL. ORs were determined by logistic regression and adjusted for age, sex, body mass index, ethnicity, hypertension, current smoking status, type 2 diabetes mellitus, HDL cholesterol, LDL cholesterol, triglycerides, apolipoprotein AI, and use of lipid medication. CHD indicates coronary heart disease; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; MI, myocardial infarction; and OR, odds ratio.